Company news

Heartbeam, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

August 28, 2025

HeartBeam's (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology

August 22, 2025

HeartBeam Reports Second Quarter 2025 Results

August 13, 2025

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4: 30 p.m. Eastern Time

July 30, 2025

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

July 22, 2025

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

June 17, 2025

HeartBeam Reports First Quarter 2025 Results

May 13, 2025

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 6, 2025

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 5, 2025

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4: 30 p.m. Eastern Time

May 1, 2025

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

April 29, 2025

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

April 24, 2025

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

March 13, 2025

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

March 6, 2025

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4: 30 p.m. Eastern Time

February 27, 2025

HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock

February 25, 2025

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

February 12, 2025

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

January 28, 2025

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

December 15, 2024

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

November 18, 2024

HeartBeam Reports Third Quarter 2024 Results

November 6, 2024

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4: 30 p.m. Eastern Time

October 30, 2024

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

October 16, 2024

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

September 23, 2024

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

September 9, 2024

HeartBeam Reports Second Quarter 2024 Results

August 13, 2024

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4: 30 p.m. Eastern Time

July 31, 2024

HeartBeam Added to Russell Microcap® Index

June 30, 2024

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

May 19, 2024

HeartBeam Reports First Quarter 2024 Results

May 8, 2024

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

March 19, 2024

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

March 13, 2024

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

March 6, 2024

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4: 30 p.m. Eastern Time

March 4, 2024

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

December 13, 2023

HeartBeam Reports Third Quarter 2023 Financial Results

November 13, 2023

HeartBeam Announces Expansion of Its Scientific Advisory Board

November 8, 2023

HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias

November 6, 2023

HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team

September 25, 2023

HeartBeam Reports Second Quarter 2023 Financial Results

August 9, 2023

HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks

August 8, 2023

HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs

August 7, 2023

HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors

July 25, 2023

HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors

June 7, 2023

HeartBeam Enters into Strategic Alliance Agreement with Samsung

May 29, 2023

HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System

May 24, 2023

HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System

May 17, 2023

HeartBeam Reports First Quarter 2023 Financial Results

May 10, 2023

HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance

May 2, 2023

HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results

March 15, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks

The 5 newest of 21 decks. Every deck is listed under its year.